TY - JOUR T1 - Landscape analysis of phase 2/3 clinical trials of targeted radionuclide therapy JF - Journal of Nuclear Medicine JO - J Nucl Med DO - 10.2967/jnumed.120.258103 SP - jnumed.120.258103 AU - Erik Mittra AU - Amanda Abbott AU - Lisa Bodei Y1 - 2021/02/01 UR - http://jnm.snmjournals.org/content/early/2021/02/12/jnumed.120.258103.abstract N2 - 300 Multiple ChoicesThis is a pdf-only article and there is no markup to show you.full-text.pdf ER -